RxDoctor Payments Data

Samuel Chacon

Reno, NVNPI 1215991856

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Boston Scientific at 49.6% of the total. Reporting peaked in 2022 at $9,797 and has fallen 99.8% since, to $17 in 2024.

$16,829in general payments, 2019–2025

Across 155 payments — averaging $108.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$8K
  • Caldera Medical, Inc$5K
  • Intuitive Surgical$1K
  • Astellas Pharma US Inc$652
  • AbbVie$550
  • Therapeuticsmd, Inc.$284
  • plus $964 from 18 others

What the payments were for

  • Consulting fees$9,90059%
  • Travel & lodging$2,25213%
  • Food & beverage$4,09624%
  • Education$5803%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →